Ga onbeperkt met Magzter GOLD
Krijg onbeperkte toegang tot meer dan 9000 tijdschriften, kranten en Premium-verhalen voor slechts
Poging GOUD - Vrij
Does US cancer drug nod make Cipla attractive?
Mint Chennai
|April 18, 2025
Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches
Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?
"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."
Dit verhaal komt uit de April 18, 2025-editie van Mint Chennai.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint Chennai
Mint Chennai
SC says courts can't impose timelines on Prez, state guvs
The ruling comes even as several states are struggling with delayed assent to important laws
2 mins
November 21, 2025
Mint Chennai
Lots of art and Christmas joy
A Mint guide to what's happening in and around the city
1 min
November 21, 2025
Mint Chennai
US's job additions surprise in Sep
US employers added a surprisingly solid 119,000 jobs in September, the government said, issuing a key economic report that had been delayed for seven weeks by the federal government shutdown.
1 min
November 21, 2025
Mint Chennai
India foodgrain harvest up 8%
India’s foodgrain production rose 8% to a record 357.73 million tonnes (mt) in the 2024-25 crop year ended June, according to government data released on Thursday.
1 min
November 21, 2025
Mint Chennai
Standardize expenditure heads by FY28: CAG tells states
CAG's move is aimed at overhauling India's public finance system.
1 min
November 21, 2025
Mint Chennai
Let's consign the money illusion firmly to history
Is very low inflation a problem? It doesn't suit everyone, admittedly, but the cost of living kept in tight control has wide and enduring economic benefits that go beyond the obvious
3 mins
November 21, 2025
Mint Chennai
Reliance brings in Carrefour exec to boost grocery play
Carrefour senior leader Guillaume de Colonges to oversee Reliance Retail’s grocery business
2 mins
November 21, 2025
Mint Chennai
Lenovo India Q2 revenue jumps 23%
Integrated IT solutions provider Lenovo's India arm on Thursday reported a 23% year-on-year increase in revenue at $1.2 billion in the September quarter, aided by strong demand fuelled by digitisation, premiumisation and improved consumer sentiment following goods and services tax (GST) rejig.
1 min
November 21, 2025
Mint Chennai
Cracks are appearing in OpenAI’s dominant facade
THE 21ST-CENTURY tech landscape was built with a winner-takes-all mindset. It started with Microsoft’s Windows monopoly at the end of the 1990s. Since then Alphabet-owned Google has cornered search and Amazon has become the king of e-commerce. Meta, too, has blanketed much of the world with social media—though on November 18th, a judge in Washington, DC, spared it the ignominy of being declared a monopolist.
2 mins
November 21, 2025
Mint Chennai
Street scales 13-month high as index heavyweights fire
November, showed NSDL data. As of Thursday, FPIs' cumulative net short index futures stood at 165,565 contracts. Covering a part of these can also take the Nifty and Sensex to new highs.
2 mins
November 21, 2025
Listen
Translate
Change font size